APA (7th ed.) Citation

Sachpekidis, C., Hassel, J. C., & Dimitrakopoulou-Strauss, A. (2016). 18F-FDG PET/CT reveals disease remission in a patient with ipilimumab-refractory advanced melanoma treated with pembrolizumab. Clinical nuclear medicine, 41(2), . https://doi.org/10.1097/RLU.0000000000001039

Chicago Style (17th ed.) Citation

Sachpekidis, Christos, Jessica C. Hassel, and Antonia Dimitrakopoulou-Strauss. "18F-FDG PET/CT Reveals Disease Remission in a Patient with Ipilimumab-refractory Advanced Melanoma Treated with Pembrolizumab." Clinical Nuclear Medicine 41, no. 2 (2016). https://doi.org/10.1097/RLU.0000000000001039.

MLA (9th ed.) Citation

Sachpekidis, Christos, et al. "18F-FDG PET/CT Reveals Disease Remission in a Patient with Ipilimumab-refractory Advanced Melanoma Treated with Pembrolizumab." Clinical Nuclear Medicine, vol. 41, no. 2, 2016, https://doi.org/10.1097/RLU.0000000000001039.